Fentanyl ‘Nuke’ & Anti-Woke Crusade: Palantir CEO’s Wild Earnings Call Fuels $490 B AI Surge 4 November 2025 Artificial Intelligence · Business · Corporate Leadership · NYSE:PLTR · Pharmaceuticals · Technology News
